◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Quest PharmaTech Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2025Jan 31, 2025 FY 2024Jan 31, 2024 FY 2023Jan 31, 2023 FY 2022Jan 31, 2022
Total Revenue 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00
Selling General And Administration 488,104 772,959 497,989 620,337
General And Administrative Expense 488,104 772,959 497,989 620,337
Research And Development 329,181 542,861 336,227 170,236
Operating Expense 817,285 1.3M 834,216 790,573
Operating Income -817,285 -1.3M -834,216 -790,573
EBIT -1.8M -3.0M -64.9M -85.0M
Interest Expense 22,644 20,680 21,002 13,063
Interest Expense Non Operating 22,644 20,680 21,002 13,063
Interest Income -- -- -- 0.00
Interest Income Non Operating -- -- -- 0.00
Net Interest Income -22,644 -20,680 -21,002 -13,063
Other Income Expense -961,129 -1.7M -64.0M -84.2M
Other Non Operating Income Expenses 300,000 170,717 450,000 241,255
Special Income Charges -- -- -- 0.00
Gain On Sale Of Security -458,786 -1.3M -61.4M -26.7M
Earnings From Equity Interest -802,343 -516,276 -3.1M -57.8M
Pretax Income -1.8M -3.0M -64.9M -85.0M
Tax Provision 0.00 0.00 0.00 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -1.8M -3.0M -64.9M -85.0M
Net Income From Continuing Operation Net Minority Interest -1.8M -3.0M -64.9M -85.0M
Net Income Including Noncontrolling Interests -1.8M -3.0M -64.9M -85.0M
Net Income Common Stockholders -1.8M -3.0M -64.9M -85.0M
Net Income -1.8M -3.0M -64.9M -85.0M
EBITDA -1.8M -3.0M -64.9M -85.0M
Normalized EBITDA -1.3M -1.7M -3.5M -58.3M
Reconciled Depreciation 0.00 2,972 13,486 38,562
Basic EPS -0.01 -0.02 -0.38 -0.51
Diluted EPS -0.01 -0.02 -0.38 -0.51
Basic Average Shares 169.1M 169.1M 168.4M 168.2M
Diluted Average Shares 169.1M 169.1M 168.4M 168.2M
Total Unusual Items -458,786 -1.3M -61.4M -26.7M
Total Unusual Items Excluding Goodwill -458,786 -1.3M -61.4M -26.7M
Tax Rate For Calcs 0.00 0.00 0.00 0.00
Normalized Income -1.3M -1.7M -3.5M -58.3M
Diluted NI Availto Com Stockholders -1.8M -3.0M -64.9M -85.0M
Gain On Sale Of Business -- -- -- 0.00
Net Income Continuous Operations -1.8M -3.0M -64.9M -85.0M
Net Non Operating Interest Income Expense -22,644 -20,680 -21,002 -13,063
Other Gand A 488,104 772,959 497,989 620,337
Total Expenses 817,285 1.3M 834,216 790,573
Total Operating Income As Reported -817,285 -1.3M -834,216 --
Line Item FY 2025Jan 31, 2025 FY 2024Jan 31, 2024 FY 2023Jan 31, 2023 FY 2022Jan 31, 2022
Cash And Cash Equivalents 205,085 716,963 374,658 264,340
Cash Cash Equivalents And Short Term Investments 205,085 716,963 374,658 264,340
Cash Financial 205,085 716,963 374,658 264,340
Accounts Receivable -- -- 221,311 320.00
Receivables -- 100,000 221,311 320.00
Prepaid Assets 20,194 18,567 25,533 23,490
Current Assets 225,279 835,530 621,502 288,150
Gross PPE -- 554,340 554,340 791,656
Accumulated Depreciation -- -554,340 -551,368 -775,239
Net PPE -- 0.00 2,972 16,417
Investments And Advances 22.3M 23.6M 26.2M 90.7M
Long Term Equity Investment 5.3M 6.1M 7.3M 10.5M
Total Non Current Assets 22.3M 23.6M 26.2M 90.7M
Total Assets 22.6M 24.5M 26.8M 91.0M
Current Debt 1.0M 1.0M 1.0M 500,000
Current Debt And Capital Lease Obligation 1.0M 1.0M 1.0M 513,998
Payables And Accrued Expenses 168,343 322,777 106,406 108,599
Current Liabilities 1.2M 1.3M 1.1M 622,597
Long Term Debt And Capital Lease Obligation -- -- -- 0.00
Long Term Capital Lease Obligation -- -- -- 0.00
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00
Total Liabilities Net Minority Interest 1.2M 1.3M 1.1M 622,597
Common Stock 30.7M 30.7M 30.7M 30.6M
Capital Stock 30.7M 30.7M 30.7M 30.6M
Additional Paid In Capital 11.7M 11.6M 11.1M 11.1M
Retained Earnings -20.9M -19.1M -16.1M 48.8M
Gains Losses Not Affecting Retained Earnings -151,471 -110,664 -114,490 -50,335
Other Equity Adjustments -151,471 -110,664 -114,490 -50,335
Common Stock Equity 21.4M 23.2M 25.7M 90.4M
Stockholders Equity 21.4M 23.2M 25.7M 90.4M
Total Equity Gross Minority Interest 21.4M 23.2M 25.7M 90.4M
Total Capitalization 21.4M 23.2M 25.7M 90.4M
Net Tangible Assets 21.4M 23.2M 25.7M 90.4M
Tangible Book Value 21.4M 23.2M 25.7M 90.4M
Working Capital -943,064 -487,247 -484,904 -334,447
Invested Capital 22.4M 24.2M 26.7M 90.9M
Total Debt 1.0M 1.0M 1.0M 513,998
Net Debt 794,915 283,037 625,342 235,660
Share Issued 169.1M 169.1M 169.1M 168.2M
Ordinary Shares Number 169.1M 169.1M 169.1M 168.2M
Capital Lease Obligations -- -- 0.00 13,998
Current Capital Lease Obligation -- -- 0.00 13,998
Held To Maturity Securities 17.0M 17.5M 18.8M 80.2M
Investmentin Financial Assets 17.0M 17.5M 18.8M 80.2M
Leases -- -- 10,224 10,224
Machinery Furniture Equipment -- 96,357 96,357 139,965
Non Current Prepaid Assets 5,855 5,855 10,420 10,420
Other Current Borrowings 1.0M 1.0M 1.0M 500,000
Other Properties -- 457,983 457,983 641,467
Other Receivables -- 100,000 221,311 --
Properties -- -- 0.00 0.00
Line Item FY 2025Jan 31, 2025 FY 2024Jan 31, 2024 FY 2023Jan 31, 2023 FY 2022Jan 31, 2022
Operating Cash Flow -511,878 -342,418 -554,683 -170,776
Cash Flow From Continuing Operating Activities -511,878 -342,418 -554,683 -170,776
Depreciation And Amortization 0.00 2,972 13,486 38,562
Depreciation Amortization Depletion 0.00 2,972 13,486 38,562
Stock Based Compensation 84,000 471,534 153,000 270,500
Change In Working Capital -156,061 249,213 -225,227 82,051
Changes In Account Receivables -- -- -- 32,410
Change In Receivables 0.00 21,311 -220,991 32,410
Change In Payables And Accrued Expense -154,434 216,371 -2,193 23,525
Net Investment Purchase And Sale -- -- -- 0.00
Investing Cash Flow 0.00 0.00 -13,999 -13,998
Cash Flow From Continuing Investing Activities -- 0.00 -13,999 -13,998
Issuance Of Debt 0.00 200,000 500,000 250,000
Repayment Of Debt 0.00 -200,000 0.00 --
Net Issuance Payments Of Debt 0.00 0.00 500,000 250,000
Issuance Of Capital Stock -- 0.00 90,000 0.00
Net Common Stock Issuance -- 0.00 90,000 0.00
Financing Cash Flow 0.00 684,723 679,000 250,000
Cash Flow From Continuing Financing Activities 0.00 684,723 679,000 250,000
Changes In Cash -511,878 342,305 110,318 65,226
Beginning Cash Position 716,963 374,658 264,340 199,114
End Cash Position 205,085 716,963 374,658 264,340
Free Cash Flow -511,878 -342,418 -554,683 -170,776
Income Tax Paid Supplemental Data -- 0.00 0.00 --
Interest Paid Supplemental Data -- 0.00 2,346 --
Amortization Cash Flow 0.00 2,972 13,486 38,562
Amortization Of Intangibles 0.00 2,972 13,486 38,562
Asset Impairment Charge -- -- -- 0.00
Change In Prepaid Assets -1,627 11,531 -2,043 26,116
Common Stock Issuance -- 0.00 90,000 0.00
Earnings Losses From Equity Investments 1.3M 1.9M 64.5M 84.5M
Gain Loss On Sale Of Business -- 0.00 -90,000 -28,318
Gain Loss On Sale Of PPE -- -- 0.00 1,946
Net Income From Continuing Operations -1.8M -3.0M -64.9M -85.0M
Net Other Financing Charges -- 684,723 -- --
Net Other Investing Changes -- -- -13,999 -13,998
Net Short Term Debt Issuance 0.00 0.00 500,000 250,000
Operating Gains Losses 1.3M 1.9M 64.4M 84.5M
Proceeds From Stock Option Exercised -- 0.00 89,000 0.00
Provisionand Write Offof Assets 100,000 100,000 0.00 --
Short Term Debt Issuance 0.00 200,000 500,000 250,000
Short Term Debt Payments 0.00 -200,000 0.00 --
Unrealized Gain Loss On Investment Securities -- -- 3.8M 0.00
NEWS
Loading news...
TRENDING
Loading...